Digital health technologies in the accelerating medicines Partnership® Schizophrenia Program.
Wigman JTW, Ching AE, Chung Y, Eichi HR, Lane E, Langholm C, Vaidyam A, Byun AJS, Haidar A, Hartmann J, Nunez A, Dwyer D, Nasarudin AA, Borders O, Scott I, Tamayo Z, Matneja P, Cho KI, Addington J, Alameda LK, Arango C, Breitborde NJK, Broome MR, Cadenhead KS, Calkins ME, Chen EYH, Choi J, Conus P, Corcoran CM, Cornblatt BA, Diaz-Caneja CM, Ellman LM, Fusar-Poli P, Gaspar PA, Gerber C, Glenthøj LB, Horton LE, Hui CLM, Kambeitz J, Kambeitz-Ilankovic L, Keshavan MS, Kim SW, Koutsouleris N, Langbein K, Mamah D, Mathalon DH, Mittal VA, Nordentoft M, Pearlson GD, Perez J, Perkins DO, Powers AR 3rd, Rogers J, Sabb FW, Schiffman J, Shah JL, Silverstein SM, Smesny S, Yassin W, Stone WS, Strauss GP, Thompson JL, Upthegrove R, Verma S, Wang J, Wolf DH, Wolff P; Accelerating Medicines Partnership® Schizophrenia (AMP® SCZ); Rowland LM, D'Alfonso S, Pasternak O, Bouix S, McGorry PD, Kahn RS, Kane JM, Bearden CE, Woods SW, Shenton ME, Nelson B, Baker JT, Torous J.
Wigman JTW, et al. Among authors: pearlson gd.
Schizophrenia (Heidelb). 2025 Jun 3;11(1):83. doi: 10.1038/s41537-025-00599-w.
Schizophrenia (Heidelb). 2025.
PMID: 40461469
Free PMC article.